Clarity Asset Management’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-121
Closed -$2.88K 158
2026
Q1
$2.88K Buy
121
+1
+0.8% +$24 ﹤0.01% 262
2025
Q4
$2.91K Sell
120
-1,053
-90% -$25.5K ﹤0.01% 224
2025
Q3
$28.3K Buy
1,173
+1,056
+903% +$25.4K 0.02% 140
2025
Q2
$2.81K Sell
117
-138
-54% -$3.27K ﹤0.01% 224
2025
Q1
$6.07K Sell
255
-4,600
-95% -$109K ﹤0.01% 175
2024
Q4
$114K Buy
4,855
+83
+2% +$1.97K 0.07% 49
2024
Q3
$115K Buy
4,772
+1
+0% +$24 0.08% 46
2024
Q2
$111K Buy
4,771
+4,621
+3,081% +$108K 0.08% 47
2024
Q1
$3.52K Buy
150
+1
+0.7% +$24 ﹤0.01% 172
2023
Q4
$3.52K Buy
+149
New +$3.41K ﹤0.01% 171

Other funds holding IBD

Clarity Asset Management's IBD Position: Q2 2026 in Review

Clarity Asset Management sold out of Inspire Corporate Bond ETF (IBD) in Q2 2026, closing a stake of 121 shares — an estimated $2.88K sold.

Clarity Asset Management first reported a position in IBD in Q4 2023 and held it in 10 quarters. The position peaked at $115K in Q3 2024. 33 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Clarity Asset Management reported no remaining Inspire Corporate Bond ETF position as of Q2 2026 after selling out during the quarter.
  • Clarity Asset Management sold 121 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $2.88K.
  • Clarity Asset Management first reported a position in Inspire Corporate Bond ETF in Q4 2023 and held it in 10 quarters.
  • Clarity Asset Management's Inspire Corporate Bond ETF position peaked at $115K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Clarity Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.